![]() AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ![]() Vigil Neuroscience Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases. | ||||
Founding Date | Founding Date 2012 | Founding Date 2020 | Founding Date 2003 | Founding Date 2001 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Irvine, US HQ Newport Beach, US | Locations Cambridge, US HQ | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Rockville, US HQ Hangzhou, CN |
Employees | Employees 6 | Employees 34 | Employees 58 | Employees 811% decrease | Employees 303% decrease |
Valuation ($) | Valuation ($) 39.5 m | Valuation ($) 151.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($39.2m) (FY, 2025) | Net income ($84.3m) (FY, 2024) | Net income (£14.9m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3.9m (about 7 years ago) | Latest funding round $ 95.9m (over 5 years ago) |
Total funding raised | Total funding raised $ 112.6m | Total funding raised $ 140m | Total funding raised $ 66.8m | Total funding raised $ 41.5m | Total funding raised $ 95.9m |

Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases.
View company
e-therapeutics is a computational drug discovery company.
View company
Domain Therapeutics is a biopharmaceutical company.
View company
Innoforce Pharmaceuticals is a company operating a biotech operation park.
View company